Welcome to LookChem.com Sign In|Join Free

CAS

  • or

5024-67-9

Post Buying Request

5024-67-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5024-67-9 Usage

Chemical compound

1,2-Benzenediamine, N-(6-methyl-3-pyridinyl)-

Primary use

Intermediate in the synthesis of dyestuffs and pigments

Physical state

Solid at room temperature

Solubility

Insoluble in water, soluble in organic solvents

Safety classification

Skin and eye irritant

Handling precautions

Handle with caution

Environmental impact

May have hazardous effects on aquatic life

Disposal

Use and dispose of responsibly to minimize environmental impact

Check Digit Verification of cas no

The CAS Registry Mumber 5024-67-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,0,2 and 4 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 5024-67:
(6*5)+(5*0)+(4*2)+(3*4)+(2*6)+(1*7)=69
69 % 10 = 9
So 5024-67-9 is a valid CAS Registry Number.

5024-67-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-N-(6-methylpyridin-3-yl)benzene-1,2-diamine

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:5024-67-9 SDS

5024-67-9Downstream Products

5024-67-9Relevant articles and documents

FUSED CYCLIC UREA DERIVATIVES AS CRHR2 ANTAGONIST

-

Paragraph 0150; 0269, (2019/11/04)

The present invention relates to fused cyclic urea derivatives which have antagonistic activities against CRHR1 and/or CRHR2, and which are useful in the treatment or prevention of disorders and diseases in which CRHR1 and/or CRHR2 is involved. The invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CRHR1 and/or CRHR2 is involved.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 5024-67-9